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Abstract
The Rab11-FIPs (Rab11-family interacting proteins; henceforth, FIPs) are a family of Rab11a/Rab11b/Rab25 GTPase effector
proteins implicated in an assortment of intracellular trafficking processes. Through proteomic screening, we have identified
TSG101 (tumor susceptibility gene 101), a component of the ESCRT-I (endosomal sorting complex required for transport)
complex, as a novel FIP4-binding protein, which we find can also bind FIP3. We show that a-helical coiled-coil regions of
both TSG101 and FIP4 mediate the interaction with the cognate protein, and that point mutations in the coiled-coil regions
of both TSG101 and FIP4 abrogate the interaction. We find that expression of TSG101 and FIP4 mutants cause cytokinesis
defects, but that the TSG101-FIP4 interaction is not required for localisation of TSG101 to the midbody/Flemming body
during abscission. Together, these data suggest functional overlap between Rab11-controlled processes and components of
the ESCRT pathway.
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Introduction
Animal cytokinesis is a fundamental cellular process in which a
dividing cell partitions its contents leading to the formation of two
diploid daughter cells. A key requirement of cytokinesis is the
spatial and temporal assembly and activation of an acto-myosin
contractile-ring at the equatorial cortex of the cell [1,2].
Constriction of this contractile-ring results in the formation of a
circumferential depression in the plasma membrane, known as the
cleavage furrow. Upon further ingression of this furrow, in a
process requiring additional constriction of the contractile-ring as
well as insertion of new membrane into the cleavage furrow, a
membrane-bound intercellular bridge known as the midbody is
formed. Cytokinesis is completed by severance of the midbody in a
process known as abscission. During the past decade, a significant
amount of information has emerged which implicates disparate
endosomal protein machinery in the processes of abscission
(reviewed in [3]). Prominent among these reports are components
of the ESCRT (endosomal sorting complex required for transport)
complexes, as well as members of the Rab GTPase family.
ESCRTs (ESCRT-0, ESCRT-I, ESCRT-II and ESCRT-III)
are multi-component protein complexes that are conserved from
archaea to animals and are implicated in the trafficking of
endosomal cargo destined for lysosomal degradation as well as
multivesicular body (MVB) biogenesis [4,5]. They recognise
ubiquitinated receptors and facilitate their sorting into endosomal
membrane invaginations by deforming the membrane during
inward vesiculation of MVBs [6]. ESCRTs then function in the
scission events that result in generation of the intraluminal vesicles
(ILVs) within MVBs [6]. ESCRTs have also been implicated in
further cellular processes requiring membrane scission events;
namely, the budding of enveloped viruses and closure of the
intercellular bridge during cytokinetic abscission [7–10]. In this
respect, one of the four proteins that constitute the ESCRT-I
complex, TSG101 (tumor susceptibility gene 101) (Vps23 in yeast),
is recruited to the Flemming body during cytokinesis and is
required for successful completion of abscission [11–15]. The
ESCRT-III complex is also necessary for abscission [14,16–18].
In humans, Rab GTPases are a family of over 60 proteins that
act as key regulators of all stages of intracellular membrane
trafficking [19]. They act as molecular switches by alternating
between active and inactive conformations which are dependent
upon the nucleotide-bound state of the Rab [19]. When GTP-
bound, Rab proteins are active and execute precise trafficking
steps through the recruitment of downstream effector proteins
[19,20]. Members of the Rab11-subfamily (Rab11a, Rab11b and
Rab25) are distributed to endosomal membranes, and among their
identified effectors are a conserved protein family termed the
Rab11-FIPs (Rab11-family interacting proteins; henceforth, FIPs),
which bind Rab11 via a carboxy-terminal Rab11-binding domain
(RBD) [21]. The class I FIPs (RCP, Rip11 and FIP2) contain C2-
domains at their amino-termini and have been implicated in the
recycling of a variety of endocytic cargoes [21]. Conversely, the
class II FIPs have amino-terminal EF-hand motifs and FIP3 has an
extensive amino-terminal proline-rich region (PRR) [21]. FIP3, in
conjunction with Rab11, is involved in endosomal-recycling
processes [22,23]; and FIP4 plays a role in the regulation of
retinal development in zebrafish (Danio rerio) [24,25]. Additionally,
both class II FIPs have been implicated in the abscission step of
cytokinesis [3,21,26–29].
While FIP4 has been implicated in retinal development and
cytokinesis, it is perhaps the FIP for which the least data exists in the
PLoS ONE | www.plosone.org 1 February 2012 | Volume 7 | Issue 2 | e32030literature. Here, we have embarked on a yeast two-hybrid proteomic
screen to identify novel FIP4-binding proteins and through this, and
subsequent experiments, have identified the ESCRT-I component
TSG101 as a novel binding-partner for both of the class II FIPs.
Results
TSG101 is a novel binding-partner for the class II FIPs
To identify novel FIP4-interacting proteins, full-length FIP4 was
used as bait to screen an adult human brain cDNA library using the
yeast two-hybrid system. Forty resultant clones were sequenced; of
which 18 corresponded to FIP4 itself, and five corresponded to FIP3.
Given that the class II FIPs are known to dimerise in the yeast two-
hybrid system [30,31], these data indicate that the screen was
successful. Of the remaining 17 clones, seven were determined to be
TSG101. To determine if further members of the FIP family could
also bind TSG101, we tested the ability of each of the FIPs to bind
TSG101 in the yeast two-hybrid system. For these experiments, L40
Saccharomyces cerevisiae were co-transformed with constructs encoding
TSG101 and each of the FIPs, and assayed for the ability of
transformed yeast to grow on selective medium lacking histidine. We
found that while TSG101 displayed no binding to the class I FIPs, it
interacted with both FIP3 and FIP4 (Figure 1A). Biochemical
experiments in HeLa cells confirmed this result as Xpress-fused FIP3
and FIP4 could co-immunoprecipitate GFP-fused TSG101
(Figure 1B). Next, we examined the distribution of the class II FIPs
withrespecttothat ofTSG101in HeLa cellsbyconfocalmicroscopy.
Previous studies have demonstrated that exogenously-expressed class
II FIPs predominantly localise to the Rab11-positive endosomal-
recycling compartment (ERC), and that their overexpression
compacts this compartment, as well as many class II FIP-binding
proteins, into a pericentrosomal location [22,23,26,30,32]. In
interphase HeLa cells, we found that when Xpress-FIP3 or FIP4
were co-expressed with GFP-TSG101, the FIP proteins were
predominantly present in the perinuclear region of the cell, while
the TSG101 was found in punctate structures dispersed throughout
the cell (Figure 1C). The degree of co-localisation observed between
the class II FIPs and TSG101 varied widely between cells;
approximately 37% of cells co-expressing Xpress-FIP3 and GFP-
TSG101 and 32% of cells co-expressing Xpress-FIP4 and GFP-
TSG101 displayed little or no co-localisation; approximately 46%
(FIP3/TSG101) and 47% (FIP4/TSG101) had limited, albeit some,
co-localisation; and approximately 17% (FIP3/TSG101) and 21%
(FIP4/TSG101) displayed strong co-localisation which was usually
most evident in cells expressing relatively high levels of both proteins
(Figure 1C; arrow in lower panel). As the class II FIPs and TSG101
have previously been implicated in cytokinesis, we also examined the
distribution of the class II FIPs with respect to TSG101 in cells
undergoing the terminal stages of cell division. Consistent with
previous studies [26–29,33], we found that during cytokinesis, the
class II FIPs localised within the midbody, the membrane-bounded
intercellular canal between the dividing cell (Figure 1D). As expected
[11,13], GFP-TSG101 was also found within the midbody, but unlike
theclass II FIPs, itwaspredominantlypresenton the Flemming body,
the electron-dense centre of the midbody (also known as the
midbody-ring) (Figure 1D). While both sets of proteins were present
within the midbody in cells undergoing abscission/cytokinesis, little
co-localisation was observed between either of the class II FIPs and
TSG101 (Figure 1D, insets).
a-helical coiled-coil regions in both TSG101 and FIP4
mediate the interaction between the two proteins
To further explore the significance of the class II FIP-TSG101
associations, we concentrated our efforts on the TSG101/FIP4
interaction. In order to generate TSG101 and FIP4 mutants that
should act as dominant-negative mutants with respect to the
cognate protein, we mapped the regions of the TSG101 and FIP4
proteins that mediate this interaction. For this work, an extensive
range of TSG101 and FIP4 truncation mutants were generated,
and their ability to bind the cognate protein tested in the yeast
two-hybrid system (Figure 2 and Figure 3). We narrowed down the
minimal FIP4-binding region of TSG101 to amino acid residues
235–313, which corresponds to the a-helical coiled-coil domain
present in TSG101 (Figure 2). Further truncation of this a-helical
coiled-coil domain disrupted the interaction (Figure 2). Similarly,
we found that an a-helical coiled-coil region of FIP4, amino acids
364–519, mediated the interaction with TSG101, and that further
truncation of this region also blocked the interaction (Figure 3).
Next, we sought to create full-length TSG101 and FIP4 proteins
that had point mutations rendering them unable to bind the
cognate protein. To this end, we utilised the Paircoil algorithm [34]
to predict the effect of a proline substitution for each of the amino
acids within the a-helical coiled-coil domains of TSG101 and FIP4
on the probability of a-helical coiled coil formation. From these
predictions, three TSG101 point mutants (K257P, V274P and
N287P) and six FIP4 point mutants (L375P, E390P, L443P,
E453P, L487P and A495P) were identified as being likely to
perturb TSG101 and FIP4 a-helical coiled-coil formation (Figure
S1 and Figure S2). We then tested the ability of each of these
mutants to bind the cognate protein in the yeast two-hybrid system
and found that two of the three TSG101 point mutants (K257P
and V274P) abrogated the interaction with FIP4 (Figure 2), and
two of the six FIP4 point mutants (L487P and A495P) blocked the
interaction with TSG101 (Figure 3).
Expression of TSG101 and FIP4 dominant-negative
mutants result in cytokinesis defects
As TSG101 and FIP4 have been previously implicated in
cytokinesis [11,13,27,28], we investigated the effect of expression
of the aforementioned TSG101 and FIP4 truncation and point
mutants on the ability of cells to successfully complete cytokinesis.
In addition, as FIP4 is a Rab11 effector protein, we also generated
a FIP4 mutant that was deficient in Rab11a-binding and tested its
ability to prevent successful cytokinesis. Previous studies have
shown that point mutations in the conserved YID/YMD motif
within the RBD of the FIPs blocks the interaction with Rab11a
[32,35] (also see Figure S3A). Therefore, constructs encoding
GFP-fusions of FIP4 that had point mutations in this YID/YMD
motif (M618E and D619A) were generated, and their ability to co-
localise with endogenous Rab11a in HeLa cells assessed by
confocal microscopy. We found that, relative to the wild-type
protein, the FIP4 M618E and D619A mutants were considerably
distributed to the cytosol, and displayed reduced co-localisation
with Rab11a (Figure S3B). Nevertheless, in some cells, these
mutants retained co-localisation with Rab11a, indicative that they
retained some, albeit likely reduced, ability to bind Rab11a (Figure
S3B). Therefore, we created a FIP4 mutant in which we
substituted the FIP4 YID/YMD motif with three alanine residues
(YMD617–619AAA). When we examined the cellular distribution
of the full-length GFP-FIP4 YMD617–619AAA mutant, we found
that, unlike the wild-type GFP-FIP4 protein which strongly co-
localises with Rab11a and condenses the Rab11a-positive
compartment into the pericentrosomal region, the YMD617–
619AAA mutant was predominantly cytosolic and exhibited
virtually no co-localisation with Rab11a (Figure 4). Together,
these data indicate that the FIP4 YMD617–619AAA is deficient in
Rab11a-binding and should serve as a dominant-negative mutant
with respect to Rab11a-mediated FIP4 cellular function.
TSG101 Binds Class II Rab11-FIPs
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mutants on the ability of cells to successfully complete cytokinesis,
HeLa cells were transfected with GFP-fusions of the wild-type or
mutant TSG101 or FIP4 proteins for 36–40 hours, fixed,
immunostained for a-tubulin and their nuclei fluorescently-
labelled with DAPI, and then scored for multinucleation (two or
more nuclei). We found that in HeLa cells expressing GFP-
TSG101, approximately 29% of cells were multinucleated, and
approximately 17% of cells expressing GFP-TSG101235–313 (the
FIP4-binding region) had more than one nucleus (compare with
an approximate 6% multinucleation rate in GFP-empty vector-
expressing cells) (Figure 5A). Multinucleation in GFP-TSG101 and
GFP-TSG101235–313-expressing cells correlated with high levels of
expression of the exogenous polypeptides (data not shown).
Expression of the GFP-FIP4 wild-type protein also caused
multinucleation (12%), and expression of GFP-FIP4364–519 (the
Figure 1. TSG101 binds the class II FIPs. (A) Yeast two-hybrid analysis of the interaction between the indicated proteins. Protein-protein interactions
weredeterminedby theability ofthetransformed yeastto growon minimalmediumlackingtryptophan, leucineandhistidine(His2).EV,e m p tyv e c to r .( B)
Co-immunoprecipitation analysis of the abilityof Xpress-FIPs toco-immunoprecipitateGFP-TSG101in HeLa cells using ananti-Xpressantibody (SM,starting
material; IP, immunoprecipitate). Co-immunoprecipitated proteins were revealed using an anti-GFP antibody. GFP-empty vector (EV) was used as a control.
SM load was 3.33%. (C and D) HeLa cells were transfected with constructs encoding the indicated proteins. At 16–18 hours post-transfection, cells were
processed for immunofluorescence microscopy and immunostained with an anti-Xpress antibody. Cells expressing relatively low levels of the GFP-TSG101
proteinareshowninD. DAPIwas used tovisualise the nuclei. Images were acquired by confocal microscopy.Insetsillustratethemidbody region of dividing
cells at 2.56higher magnification. Scale bar indicates 10 mm. Data are typical of at least three independent experiments.
doi:10.1371/journal.pone.0032030.g001
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of cells to successfully complete cytokinesis, as approximately 20%
were multinucleate (Figure 5A). We also found that expression of
the FIP3 and FIP4 mutants that are deficient in Rab11a-binding
(FIP3 I738E and FIP4 YMD617–619AAA) strongly inhibited
cytokinesis as approximately 25% of cells displayed a multinucle-
ate phenotype; whereas expression of RCP I621E, an equivalent
mutant of a class I FIP, failed to result in multinucleation levels
above that of controls (Figure 5A). Consistent with a previous
study [28], we also found that expression of the dominant-negative
Rab11a mutant (Rab11a S25N) caused cytokinesis failure as
17.5% of cells were multinucleate (Figure 5A).
We also examined the effects of expression of the TSG101 and
FIP4 proteins with the single amino acid substitutions in their a-
helical coiled coil domain that, in some cases, disrupt the
interaction with the cognate protein, on the ability of cells to
successfully complete cytokinesis. We found no significant
difference in the proportion of cells displaying a multinucleation
phenotype between GFP-TSG101 wild-type, GFP-TSG101
V274P (FIP4-binding deficient mutant) or GFP-TSG101 N287P
(FIP4-binding unaffected) (Figure 5B). In addition, we found that
expression of the TSG101-binding deficient mutants of FIP4
(L487P and A495P) failed to result in multinucleation levels
significantly above that of the GFP-FIP4 wild-type protein
(Figure 5C). Notably, expression of FIP4 L375P, a FIP4 mutant
that retains its TSG101-binding ability, did result in multi-
nucleation levels above that of GFP-FIP4 wild-type (Figure 5C).
TSG101 localises to the Flemming body independently of
the class II FIPs
Previous studies have demonstrated that CEP55 (centrosome
protein 55), a centrosome and midbody protein involved in
abscission, is required for recruitment of TSG101 to the midbody
Figure 2. The coiled-coil region of TSG101 mediates the interaction with FIP4. (A) Plot depicting the probability of a-helical coiled-coil
structure formation in TSG101 as determined using the PairCoil algorithm. (B) Schematic representation of the TSG101 truncation and point mutants
that were tested for FIP4-binding ability. The outcome of the yeast two-hybrid experiments performed (part C) are indicated adjacent to the
corresponding mutant in the schematic. (C) Yeast two-hybrid analysis of the interaction between the indicated proteins. Protein-protein interactions
were determined by the ability of the transformed yeast to grow on minimal medium lacking tryptophan, leucine and histidine (His2). EV, empty
vector. Data are typical of at least three independent experiments.
doi:10.1371/journal.pone.0032030.g002
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required for localisation of TSG101 to the midbody during
cytokinesis, we investigated the ability of mCherry-TSG101 to
localise to the Flemming body in cells expressing class II FIP
dominant-negative mutants. We found that in HeLa cells co-
expressing mCherry-TSG101 together with GFP-fusions of FIP3
I738E, FIP4 YMD617–619AAA or FIP4364–519, that localisation
of the TSG101 protein to the Flemming body was not impeded
(Figure 6A). In addition, we found that like the wild-type protein,
the FIP4-binding deficient TSG101 mutant (TSG101 V274P)
localises to the Flemming body during cytokinesis (Figure 6B). We
also determined if interaction between TSG101 and FIP4 was
required for localisation of FIP4 to the midbody and found that
the TSG101-binding deficient mutants of FIP4 (FIP4 L487P and
FIP4 A495P) were not precluded from localisation to the midbody
during cytokinesis (Figure 7).
Figure 3. An extensive coiled-coil region of FIP4 mediates the interaction with TSG101. (A) Plot depicting the probability of a-helical
coiled-coil structure formation in FIP4 as determined using the PairCoil algorithm. (B) Schematic representation of the FIP4 truncation and point
mutants that were tested for TSG101-binding ability. The outcome of the yeast two-hybrid experiments performed (part C) are indicated adjacent to
the relevant mutant in the schematic. (C) Yeast two-hybrid analysis of the interaction between the indicated proteins. Protein-protein interactions
were determined by the ability of the transformed yeast to grow on minimal medium lacking tryptophan, leucine and histidine (His2). EV, empty
vector. Data are typical of at least three independent experiments.
doi:10.1371/journal.pone.0032030.g003
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During the past decade, a multitude of endosomal proteins have
been implicated in animal cytokinesis which underscores the
crucial importance of intracellular trafficking processes in the
completion of cell division [3]. In this regard, recent evidence
suggests that ESCRT-I and ESCRT-III components are sequen-
tially recruited to the central region of the intercellular bridge
where they lead to membrane deformation, and ultimately,
breakage of the midbody during abscission [15,17,18]. To identify
novel proteins implicated in Rab11-controlled cellular processes,
we performed a proteomic screen with FIP4 as bait, and have
identified TSG101 as a novel FIP4-binding protein. Upon
investigation of the extent of FIP-TSG101 interactions, we found
that TSG101 also binds FIP3, the other class II FIP. We also
found that the a-helical coiled-coil domains of FIP4 and TSG101
are sufficient for binding of the cognate protein, and that point
mutations in either of these a-helical coiled-coil domains blocks
this interaction.
Expression of GFP-fused wild-type TSG101 or FIP4 were found
to result in multinucleation in HeLa cells. These data are
consistent with previous reports implicating TSG101 and the
class II FIPs in cytokinesis [12,13,15,26–28,36], and indicate that
these proteins may form functional complexes with each other
during the terminal stages of cell division. Nevertheless, when we
examined the distribution of FIP3 and FIP4 with respect to that of
TSG101 in cytokinetic cells, we failed to detect significant
midbody co-localisation between either protein pair, despite the
presence of each of these proteins within the midbody. In addition,
while expression of TSG101 and class II FIP truncation mutants
did cause multinucleation, expression of TSG101 and FIP4 point
mutants deficient in binding the cognate protein, while also
causing multinucleation, failed to result in multinucleation levels
significantly above that of the wild-type proteins. We also found
that localisation of TSG101 to the Flemming body was not
impeded in cells expressing dominant-negative Rab11a-binding
deficient mutants of FIP3 or FIP4; and furthermore, the TSG101
V274P mutant, which cannot bind FIP4, can also localise to the
Flemming body. Together, these data indicate that while TSG101
and the class II FIPs are clearly necessary for successful completion
of cytokinesis, the class II FIPs are not required for the trafficking
of TSG101 to the midbody during telophase/cytokinesis and that
TSG101 and the class II FIPs may not form functional complexes
during cytokinesis. This raises the possibility that a functional
interaction may exist between TSG101 and the class II FIPs in
distinct ESCRT-mediated cellular events. In this regard, while it is
possible that the class II FIPs could play a role in cargo sorting or
MVB biogenesis, to our knowledge, no data exists implicating
either FIP3 or FIP4 in the endocytic degradative pathway.
Interestingly, the ESCRT complexes are implicated in the
budding of enveloped viruses [9,10], and recent reports indicate
that Rab11 is involved in influenza A virus budding and filament
formation [37]. FIP3 was also found to be required for formation
of influenza A viral filaments [37]. Furthermore, FIP4 was recently
found to bind the human cytomegalovirus (HCMV) envelope
glycoprotein M (UL100), and expression of the Rab11 S25N
(dominant-negative mutant) and depletion of FIP4 expression in
HCMV-infected cells, led to a decrease in infectious virus
production [38]. These studies point to roles for Rab11 and the
class II FIPs in the cellular events leading to viral envelopment
which may involve class II FIP/ESCRT interactions.
In summary, we have identified a component of the ESCRT-I
complex as a novel binding-partner for a subset of Rab11 effectors.
The major challenge now remains to elucidate the functional links
between Rab11, its effectors, and the ESCRT complexes; and to
determine how further Rab GTPases may influence intracellular
trafficking events along the ESCRT-pathway.
Materials and Methods
Yeast two-hybrid screen and assay
The yeast two-hybrid screen with full-length FIP4 as bait was
screened against an adult human brain cDNA library [ProQuest
human brain cDNA library (11376-027) (Invitrogen)] by Creative
Biolabs (Shirley, New York, USA). For the yeast two-hybrid assay,
constructs encoding the polypeptides of interest in pVJL10 (bait)
Figure 4. FIP4 YMD617–619AAA is deficient in Rab11-binding. HeLa cells were transfected with constructs encoding the indicated proteins.
At 16–18 hours post-transfection, cells were processed for immunofluorescence microscopy and immunostained with an anti-Rab11a antibody.
Images were acquired by confocal microscopy. Scale bar indicates 10 mm. Data are typical of at least three independent experiments.
doi:10.1371/journal.pone.0032030.g004
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the S. cerevisiae L40 reporter strain using the following procedure. A
YPD-agar plate was streaked with S. cerevisiae and incubated at
30uC until sufficient colonies had formed (3–5 days). 10 ml of YPD
media was inoculated with a colony from the YPD-agar plate and
incubated overnight at 30uC with rotation at 225 rpm. The S.
cerevisiae/YPD culture was diluted 1:10 with fresh YPD media and
incubated for 2 hours at 30uC with rotation at 225 rpm (cell
density between 10
7 and 3.0610
7 cells per ml). The cells were
pelleted by centrifugation at 5806 g, and the pellet washed with
90 ml of 0.1 M LiAc/TE. The cells were again pelleted,
resuspended in 2 ml of 0.1 M LiAc/TE, and incubated for 1 h
at 30uC with rotation at 225 rpm. For each reaction, 150 ml of the
yeast/LiAc/TE solution was added to Eppendorf tubes containing
2 mg of each of the bait and prey plasmids, and 40 mg of heat-
denatured salmon sperm DNA (Sigma), and the samples incubated
for 10 min at 30uC. 500 ml of 50% PEG/LiAc/TE was added to
each tube and the samples mixed by gentle inversion. Samples
were incubated for 1 h at 30uC, with occasional mixing and
thermally-shocked for 25 min in a water bath at 42uC, and the
cells pelleted by centrifugation at 3006 g for 5 s. The cells were
washed twice by resuspension in 1 ml of YPD media and pelleted
by centrifugation for 5 s at 3006g. The cells were resuspended in
100 ml of YPD media, plated onto agar plates containing selective
media lacking tryptophan and leucine (W
2L
2) and incubated for
2–3 days at 30uC. Colonies from each plate were resuspended in
an Eppendorf tube containing 500 mlo fd H 2O; and 5 ml of this
solution spotted onto W
2L
2 agar plates [indicated as His
+ in the
figures] or agar plates containing selective media lacking
tryptophan, leucine and histidine [(W
2L
2H
2); indicated as His
2
in the figures] and containing 0, 1, 5 or 10 mM 3-AT (3-Amino-
1,2,4-triazole), an inhibitor of auto-activation, and incubated for
2–3 days at 30uC. The resultant spots were imaged using a
FUJIFILM FinePix S602 Zoom digital camera. In all instances,





Cell line, primary antibodies and plasmid transfection
The HeLa (human cervical carcinoma) cell line, which was
obtained from the European Molecular Biology Laboratory
(EMBL) [39], was cultured in Dulbecco’s modified Eagle’s
medium supplemented with 10% (v/v) foetal bovine serum,
2 mM L-glutamine and 25 mM HEPES and grown in 5% CO2 at
37uC. The mouse monoclonal antibodies used were anti-Xpress
(Invitrogen) and anti-a-tubulin (Sigma). Rabbit polyclonal anti-
bodies used were anti-GFP (Abcam) and anti-Rab11a (Zymed).
Cells were transfected with plasmid constructs using TurboFect
(Fermentas) as transfection reagent.
Plasmid construction
The following plasmids have been previously described, sub-
cloned, generated by site-directed mutagenesis (SDM) or PCR
using the indicated primers. pEGFP-C1/FIP4 [22]; pEGFP-C1/
FIP42–363 (SDM: Fwd gacagcctgaccaatggggactagaagagcaagctgaag-
caagag, Rev ctcttgcttcagcttgctcttctagtccccattggtcaggctgtc); pEGFP-
C3/FIP4364–519 (subcloned from pGADGH/FIP4364–519); pEGFP-
C3/FIP4364–637 (subcloned from pGADGH/FIP4364–637); pEGFP-
C3/FIP4520–637 (PCR: Fwd cccggatccaccaggcaggggccgcagtgcct, Rev
cccgaattcttagtgtttgatctcgaggatggag); pEGFP-C1/FIP4 L375P (SDM:
Fwd agagaacacacagccggtgcacagggtgc, Rev gcaccctgtgcaccggctgtg-
tgttctct); pEGFP-C1/FIP4 E390P (SDM: Fwd tggtgaaggatcagcc-
gaccacggccgagc, Rev gctcggccgtggtcggctgatccttcacca); pEGFP-C1/
FIP4 L443P (SDM: Fwd aacaacagtgactcggcccaagtctcaaacagaga,
Rev tctctgtttgagacttgggccgagtcactgttgtt); pEGFP-C1/FIP4 E453P
(SDM: Fwd gagaaactggatgagccgcggcagcgcatgtc, Rev gacatgcgctgcc-
gcggctcatccagtttctc); pEGFP-C1/FIP4 L487P (SDM: Fwd gcgaca-
gaaccgccctgagttccagaagg, Rev ccttctggaactcagggcggttctgtcgc); pEGFP-
C1/FIP4 A495P (SDM: Fwd aggagcgggagccgacgcaggag, Rev
ctcctgcgtcggctcccgctcct); pEGFP-C1/FIP482–637 (subcloned from
pGADGH/FIP482–637 [30]); pEGFP-C1/FIP482–637 YMD617–
619AAA (SDM: template pEGFP-C1/-FIP482–637 D619A, Fwd
caacttccggctgaggcaggccgcggccaagattatcctcgcc, Rev ggcgaggataatcttgg-
ccgcggcctgcctcagccggaagttg); pEGFP-C1/FIP4 YMD617–619AAA
(FIP42–344 subcloned from pEGFP-C1/FIP4 into pEGFP-C1/
FIP482–637 YMD617–619AAA); pEGFP-C1/-FIP482–637 M618E
(SDM: Fwd cggctgaggcagtacgaggacaagattatcctcgc, Rev gcgaggataatctt-
gtcctcgtactgcctcagccg); pEGFP-C1/-FIP482–637 D619A (SDM: Fwd
aggcagtacatggccaagattatcctc, Rev gaggataatcttggccatgtactgcct); pEGFP-
C3/Rab11a S25N (subcloned from pGEM/Rab11a S25N [40]);
pEGFP-C3/RCP I621E [35]; pEGFP-C1/FIP3 I738E [41];
pCR3.1-GFP/TSG101 [11]; pGEX-3X/TSG101 (PCR: template
pCR3.1-GFP/TSG101, Fwd cccgaattctatggcggtgtcggagagccagc, Rev
cccgaattcctagtagaggtcactgagaccgg); pEGFP-C1/TSG101 (subcloned
from pGEX-3X/TSG101); pmCherry-C1/TSG101 (subcloned from
pGEX-3X/TSG101); pEGFP-C2/TSG101235–313 (subcloned from
pVJL10-TSG101235–313); pEGFP-C2/TSG101235–390 (subcloned
from pVJL10-TSG101235–390); pEGFP-C2/TSG101 V274P (sub-
cloned from pVJL10-TSG101 V274P); pEGFP-C1/TSG101 N287P
(SDM: Fwd tcaagaagtagccgaggttgataaacccatagaacttttgaaaaagaagga,
Rev tccttctttttcaaaagttctatgggtttatcaacctcggctacttcttga); pEGFP-C1,
pEGFP-C2 and pEGFP-C3 (Clontech); pcDNA3.1-HisB/FIP3
(Xpress-FIP3) (subcloned from pEGFP-C1/FIP3 [26]); pcDNA3.1-
HisB/FIP4 (Xpress-FIP4) (subcloned from pEGFP-C1/FIP4);
pVJL10-TSG101 (PCR: template pEGFP-C1/TSG101, Fwd cccgaa-
ttcatggcggtgtcggagagccagc, Rev cccgaattcctagtagaggtcactgagaccgg);
pVJL10-TSG1011–234 (SDM: Fwd gcctctctcatctctgcggtctaggacaaactga-
gatggcggatg, Rev catccgccatctcagtttgtcctagaccgcagagatgagagaggc);
pVJL10-TSG101235–313 (PCR: Fwd cccgaattcagtgacaaactgagatggcgga-
tga, Rev cccggatcctaatcattgttttcagactgattttccat); pVJL10-TSG101235–257
(SDM: Fwd gcagagctcaatgccttgaaatgaacagaagaagacctgaaaaag, Rev
ctttttcaggtctttcttctgttcatttcaaggcattgagctctgc); pVJL10-TSG101235–273
(SDM: Fwd caccagaaactggaagagatgtgaacccgtttagatcaagaagta, Rev
tacttcttgatctaaacgggttcacatctcttccagtttctggtg); pVJL10-TSG101274–290
(SDM: Fwd gttgataaaaacatagaactttgaaaaaagaaggatgaagaactc, Rev
gagttcttcatccttcttttttcaaagttctatgtttttatcaac); pVJL10-TSG101274–313
(PCR: Fwd cccgaattcgttacccgtttagatcaagaag, Rev cccggatcctaatcattgtttt-
cagactgattttccat); pVJL10-TSG101235–390 (PCR: Fwd cccgaattcagtga-
caaactgagatggcggatga, Rev cccggatcctcagtagaggtcactgagaccg); pVJL10-
TSG101 K257P (SDM: Fwd ggcagagctcaatgccttgccacgaacagaagaa-
gacctg, Rev caggtcttcttctgttcgtggcaaggcattgagctctgcc); pVJL10-TSG101
V274P (SDM: Fwd accagaaactggaagagatgcctacccgtttagatcaagaag, Rev
Figure 5. Expression of TSG101 and FIP4 dominant-negative mutants cause abscission failure. HeLa cells were transfected with
constructs encoding the indicated proteins. At 36–40 hours post-transfection, cells were processed for immunofluorescence microscopy,
immunostained for a-tubulin and their nuclei fluorescently-labelled with DAPI. A minimum of 150 transfected cells per experiment were counted and
scored for multinucleation (.1 nucleus). Results, from three independent experiments, are expressed as the mean percentages 6 S.D. Statistical
significance was determined using an unpaired t test to investigate: (A) the difference between empty vector and GFP-fusion means, (B) the
difference between GFP-TSG101 and GFP-TSG101 point mutant means and (C) the difference between GFP-FIP4 and GFP-FIP4 point mutant means.
Statistical significance, *p,0.05, **p,0.02. NT, non-transfected; EV, empty vector.
doi:10.1371/journal.pone.0032030.g005
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(SDM: Fwd tcaagaagtagccgaggttgataaacccatagaacttttgaaaaagaagga,
Rev tccttctttttcaaaagttctatgggtttatcaacctcggctacttcttga); pLexA/Rab11a
Q70L [42]; pGADGH (Clontech); pGADGH/RCP [42];
pGADGH/Rip11 [31]; pGADGH/FIP2 [31]; pGADGH/FIP3
(subcloned from pEGFP-C1/FIP3 [26]); pGADGH/FIP4 (subcloned
from pEGFP-C1/FIP4); pGADGH/FIP42–363 (subcloned from
pEGFP-C1/FIP42–363); pGADGH/FIP4364–637 (PCR: Fwd cccggatc-
cactgaagagcaagctgaagcaagag, Rev cccgaattcttagtgtttgatctcgaggatggag);
pGADGH/FIP4364–519 (PCR: Fwd cccggatccactgaagagcaagctgaagcaa-
gag, Rev cccgaattctaccgctcgcagtccagcttgta); pGADGH/FIP4364–412
(PCR: Fwd cccggatccactgaagagcaagctgaagcaagag, Rev cccgaattctactc-
Figure 6. TSG101 localises to the Flemming body during abscission independently of the class II FIPs. (A and B) HeLa cells were
transfected with constructs encoding the indicated proteins. At 16–18 hours post-transfection, cells were processed for immunofluorescence
microscopy and, where indicated, immunostained for a-tubulin. DAPI was used to visualise the nuclei. Images, from cells expressing relatively low
levels of the TSG101 fusion protein, were acquired by confocal microscopy. Scale bar indicates 10 mm. Data are typical of at least three independent
experiments.
doi:10.1371/journal.pone.0032030.g006
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caagggagaaggctaccgaggtgg, Rev cccgaattctacaggtccatctcatctttgagcc);
pGADGH/FIP4475–519 (PCR: Fwd cccggatccatacaagcgcatgatgga-
caagctg, Rev cccgaattctaccgctcgcagtccagcttgta); pGADGH/FIP4540–
571 (PCR: Fwd cccggatccagtggagctcgagcacgaggtc, Rev cccgaattctagct-
gaggctcaaaatctgcccat); pGADGH/FIP4572–637 (PCR: Fwd cccggatc-
cactctacgaagcaaaaaacctctttg, Rev cccgaattcttagtgtttgatctcgaggatggag);
pGADGH/FIP4 L375P (subcloned from pEGFP-C1/FIP4 L375P);
pGADGH/FIP4 E390P (SDM: Fwd tggtgaaggatcagccgaccacggccgagc,
Rev gctcggccgtggtcggctgatccttcacca); pGADGH/FIP4 L443P (SDM:
Fwd aacaacagtgactcggcccaagtctcaaacagaga, Rev tctctgtttgagacttgggcc-
gagtcactgttgtt); pGADGH/FIP4 E453P (subcloned from pEGFP-C1/
FIP4 E453P); pGADGH/FIP4 L487P (SDM: Fwd gcgacagaaccgccct-
gagttccagaagg, Rev ccttctggaactcagggcggttctgtcgc); pGADGH/FIP4
A495P (SDM: Fwd aggagcgggagccgacgcaggag, Rev ctcctgcgtcgg-
ctcccgctcct). All constructs generated by SDM or PCR were verified
by DNA sequencing (Macrogen).
Co-immunoprecipitation and immunoblotting
Subconfluent HeLa cells growing on 10 cm dishes were
transfected with the 2 mg of each of the indicated plasmids.
16 hours post-transfection, the cells were lysed in 500 ml of lysis
buffer (LB) [125 mM NaCl, 0.5% Igepal CA-630, 50 mM HEPES
pH 7.4, 1 mM MgCl2, 1 mM AEBSF, plus complete Mini,
EDTA-free protease inhibitor cocktail tablets (Roche)], passed
twice through a 26-gauge needle, and incubated on ice for 10 min.
Magnetic beads conjugated to sheep anti-mouse IgG (Dynal) were
bound to mouse anti-Xpress antibodies. Antibody-coated beads
were incubated with 440 ml of each of the lysates (60 ml was
retained as starting material) for 3 h at 4uC, under rotation at
7 rpm. Antibody-coated bead/protein complexes were precipitat-
ed by placing the tubes on the dynabead magnet. Unbound
proteins were removed, and the beads gently washed three times
with 1 ml of LB. Specifically-associated proteins were eluted from
the beads by boiling for 10 min in 60 mlo f1 6 Laemmli sample
buffer. 60 ml of each of the lysates (starting material) was boiled in
30 mlo f3 6Laemmli sample buffer. 25 ml of each of the starting
materials and eluted samples were resolved by 12% SDS-PAGE
and immunoblotted with anti-GFP and anti-Xpress antibodies.
Immunoblotting analyses were performed on an Odyssey Infrared
Imaging System and processed using the Odyssey Infrared
Imaging Application Software (LI-COR), as described in [43].
Secondary antibodies used were IRDye 680 goat anti-rabbit and
IRDye 800CW goat anti-mouse (LI-COR).
Immunofluorescence, fluorescence microscopy and data
analysis
Immunofluorescence microscopy was performed as previously
described [44]. Secondary antibodies used were Alexa Fluor 594-
conjugated goat anti-mouse (Molecular Probes) and Cy3 (indo-
carbocyanine)-conjugated donkey anti-rabbit (Jackson ImmunoR-
esearch). Images were recorded in a temperature-controlled
environment (18uC) using a Zeiss LSM 510 META confocal
microscope fitted with a 6361.4 plan apochromat lens. Images
were processed using Zeiss LSM Image Browser or Zeiss ZEN
Light Edition software and Adobe Illustrator. All micrographs
shown are 3D projections from the optical sections of the entire Z-
stack. To quantify cytokinesis failure in cells expressing GFP-fused
proteins/polypeptides, a minimum of 150 transfected cells per
experiment were counted and scored for multinucleation (.1
nucleus). Results, from three independent experiments, were
expressed as the mean percentages 6 S.D. Statistical significance
was determined using the unpaired t test function of Excel
(Microsoft), assuming one-tailed distributions and unequal vari-
ances. Significance differences were defined as discernable where
p,0.05.
Supporting Information
Figure S1 Mutation of the TSG101 coiled-coil domain
reduces the probability of coiled-coil formation. Plots
depicting the probability of a-helical coiled-coil structure forma-
Figure 7. FIP4 localises to the midbody of dividing cells independently of TSG101. HeLa cells were transfected with constructs encoding
the indicated proteins. At 16–18 hours post-transfection, cells were processed for immunofluorescence microscopy and immunostained for a-tubulin.
DAPI was used to visualise the nuclei. Images were acquired by confocal microscopy. Scale bar indicates 10 mm. Data are typical of at least three
independent experiments.
doi:10.1371/journal.pone.0032030.g007
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PairCoil algorithm.
(TIF)
Figure S2 Mutation of the FIP4 coiled-coil domain
reduces the probability of coiled-coil formation. Plots
depicting the probability of a-helical coiled-coil structure forma-
tion in wild-type and mutant FIP4 as determined using the PairCoil
algorithm.
(TIF)
Figure S3 Mutation of Rab11-binding domain of FIP4
perturbs its distribution. (A) Portion of a ClustalW alignment
of the FIPs. Identities are in black and similarities are in grey. The
conserved Rab11-binding domain (RBD) is underlined in green
and the conserved YID/YMD motif is underlined in blue. (B)
HeLa cells were transfected with constructs encoding the indicated
polypeptides. At 16–18 hours post-transfection, cells were pro-
cessed for immunofluorescence microscopy and immunostained
with an anti-Rab11a antibody. Images were acquired by confocal
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